Dallah Healthcare Company (TADAWUL:4004)
97.05
-3.05 (-3.05%)
Aug 13, 2026, 3:13 PM AST
Dallah Healthcare Company Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Dallah Healthcare Company stock has a consensus rating of "Hold" and an average price target of SAR 131.48. The average 1-year stock price forecast is 35.48% higher than the current stock price, while the lowest is SAR 114.00 (+17.47%) and the highest is SAR 160.00 (+64.86%).
Price Target: SAR 131.48 (+35.48%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Dallah Healthcare Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 2 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 3 | 2 | 2 | 3 | 6 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 2 | 2 | 2 | 2 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 9 | 9 |
Financial Forecast
Revenue This Year
4.43B
from 4.07B
Increased by 8.90%
Revenue Next Year
5.07B
from 4.43B
Increased by 14.39%
EPS This Year
4.45
from 5.32
Decreased by -16.35%
EPS Next Year
5.66
from 4.45
Increased by 27.19%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.